{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T13:54:55Z","timestamp":1697982895453},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1984,7,1]],"date-time":"1984-07-01T00:00:00Z","timestamp":457488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1984,7]]},"DOI":"10.1007\/bf00549596","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T07:06:57Z","timestamp":1100848017000},"page":"465-469","source":"Crossref","is-referenced-by-count":8,"title":["Single-dose kinetics of primidone in acute viral hepatitis"],"prefix":"10.1007","volume":"27","author":[{"given":"F.","family":"Pisani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Perucca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Primerano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M.","family":"Petrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"224","volume":"192","author":"J Alvin","year":"1975","unstructured":"Alvin J, McHorse TS, Hoyumpa A, Bush MT, Schenker S (1975) The effect of liver disease in man on the disposition of phenobarbital. J Pharmacol Exp Ther 192: 224?235 (1982)","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1528-1157.1982.tb06092.x","volume":"23","author":"JJ Asconap\u00e8","year":"1982","unstructured":"Asconap\u00e8 JJ, Penry JK (1982) Use of antiepileptic drugs in the presence of liver and kidney disease: a review. Epilepsia 23 [Suppl 1]: 65?80","journal-title":"Epilepsia"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archneur.1972.00490130036005","volume":"27","author":"IP Baumel","year":"1972","unstructured":"Baumel IP, Gallagher BB, Mattson RH (1972) Phenylethylmalonamide (PEMA): an important metabolite of primidone. Arch Neurol 27: 34?41","journal-title":"Arch Neurol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cpt1975176685","volume":"17","author":"TF Blaschke","year":"1975","unstructured":"Blaschke TF, Meffin PJ, Melmon KL, Rowland M (1975) Influence of acute viral hepatitis on phenytoin kinetics and protein binding. Clin Pharmacol Ther 17: 685?691","journal-title":"Clin Pharmacol Ther"},{"key":"CR5","first-page":"342","volume-title":"Antiepileptic drugs: quantitative analysis and interpretation","author":"HE Booker","year":"1978","unstructured":"Booker HE, Darcey BA (1978) Phenobarbital, primidone and phenytoin: simultaneous determination without derivatization. In: Pippenger CE, Penry JK, Kutt H (eds) Antiepileptic drugs: quantitative analysis and interpretation. Raven Press, New York, pp 342?345"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1528-1157.1970.tb03905.x","volume":"11","author":"HE Booker","year":"1970","unstructured":"Booker HE, Hosokowa RD, Darcey B (1970) A clinical study of serum primidone levels. Epilepsia 11: 395?402","journal-title":"Epilepsia"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1212\/WNL.33.3.283","volume":"33","author":"BFD Bourgeois","year":"1983","unstructured":"Bourgeois BFD, Dodson WE, Ferrandelli JA (1983) Primidone, phenobarbital and PEMA: I. Seizures protection, neurotoxicity, and therapeutic index of individual compounds in mice. Neurology 33: 283?290","journal-title":"Neurology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1981.55","volume":"29","author":"JC Cloyd","year":"1981","unstructured":"Cloyd JC, Miller KW, Leppik IE (1981) Primidone kinetics: effects of concurrent drugs and duration of therapy. Clin Pharmacol Ther 29: 402?407","journal-title":"Clin Pharmacol Ther"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1528-1157.1982.tb06196.x","volume":"23","author":"PR Cottrell","year":"1982","unstructured":"Cottrell PR, Streete JM, Berry DJ, Sch\u00e4fer H, Pisani F, Perucca E, Richens A (1982) Pharmacokinetics of phenylethylmalonamide (PEMA) in normal subjects and in patients treated with antiepileptic drugs. Epilepsia 23: 307?313","journal-title":"Epilepsia"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3181\/00379727-140-36487","volume":"140","author":"J Doshi","year":"1972","unstructured":"Doshi J, Luisada-Opper A, Leevy C (1972) Microsomal pentobarbital hydroxylase activity in acute viral hepatitis. Proc Soc Exp Biol Med 140: 492?495","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR11","first-page":"429","volume-title":"Antiepileptic drugs","author":"RW Fincham","year":"1982","unstructured":"Fincham RW, Schottelius DD (1982) Primidone. Relation of plasma concentration to seizure control. In: Woodbury DM, Penry JK, Pippenger CE (eds), Antiepileptic drugs. Raven Press, New York, pp 429?440"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/WNL.22.11.1186","volume":"22","author":"BB Gallagher","year":"1972","unstructured":"Gallagher BB, Baumel IP, Mattson RH (1972) Metabolic disposition of primidone and its metabolites in epileptic subjects after single and repeated administration. Neurology 22: 1186?1192","journal-title":"Neurology"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1528-1157.1970.tb03893.x","volume":"11","author":"BB Gallagher","year":"1970","unstructured":"Gallagher BB, Smith DB, Mattson RH (1970) The relationship of the anticonvulsant properties of primidone to phenobarbital. Epilepsia 11: 293?301","journal-title":"Epilepsia"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cpt1977222200","volume":"22","author":"RE Kauffman","year":"1977","unstructured":"Kauffman RE, Habersang R, Lansky L (1977) Kinetics of primidone metabolism and excretion in children. Clin Pharmacol Ther 22: 200?205","journal-title":"Clin Pharmacol Ther"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archneur.1964.00460240081011","volume":"11","author":"H Kutt","year":"1964","unstructured":"Kutt H, Winters W, Scherman R, McDowell F (1964) Diphenylhydantoin and phenobarbital toxicity. The role of liver disease. Arch Neurol 11: 649?656","journal-title":"Arch Neurol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF03189627","volume":"7","author":"APS Narang","year":"1982","unstructured":"Narang APS, Data DV, Nath N, Mathur VS (1982) Impairment of hepatic drug metabolism in patients with acute viral hepatitis. Eur J Drug Metab Pharmacokinet 7: 255?258","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"CR17","first-page":"237","volume-title":"Antiepileptic therapy: advances in drug monitoring","author":"J Oxley","year":"1980","unstructured":"Oxley J, Hebdige S, Laidlaw J, Wadsworth J, Richens A (1980) A comparative study of phenobarbitone and primidone in the treatment of epilepsy. In: Johannessen SI, Morselli PL, Pippenger CE, Richens A, Schmidt D, Meinardi H (eds), Antiepileptic therapy: advances in drug monitoring, Raven Press, New York, pp 237?245"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2165\/00003088-198308030-00006","volume":"8","author":"F Pisani","year":"1983","unstructured":"Pisani F, Richens A (1983) Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration. Clin Pharmacokinet 8: 272?276","journal-title":"Clin Pharmacokinet"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00562499","volume":"4","author":"B Schoene","year":"1972","unstructured":"Schoene B, Fleischmann RA, Remmer H, Oldershausen HFV (1972) Determination of drug metabolizing enzymes in needle biopsies of human liver. Eur J Clin Pharmacol 4: 65?73","journal-title":"Eur J Clin Pharmacol"},{"key":"CR20","first-page":"149","volume-title":"Clinical pharmacology of antiepileptic drugs","author":"AL Sherwin","year":"1975","unstructured":"Sherwin AL (1975) General discussion. In: Schneider H, Janz D, Gardner-Thorpe C, Sherwin AL (eds) Clinical pharmacology of antiepileptic drugs. Springer, Berlin Heidelberg New York pp 149"},{"key":"CR21","first-page":"129","volume-title":"Epileptology","author":"P Zavadil","year":"1976","unstructured":"Zavadil P, Gallagher BB (1976) Metabolism and excretion of 14C-primidone in epileptic patients. In: Janz D (ed) Epileptology, Georg Thieme, Stuttgart, pp 129?138"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/03602537508993754","volume":"4","author":"GR Wilkinson","year":"1975","unstructured":"Wilkinson GR, Schenker S (1975) Drug disposition and liver disease. Drug Metab Rev 4: 139?175","journal-title":"Drug Metab Rev"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2165\/00003088-198005060-00002","volume":"5","author":"RL Williams","year":"1980","unstructured":"Williams RL, Mamelok RD (1980) Hepatic disease and drug pharmacokinetics. Clin Pharmacokinet 5: 528?548","journal-title":"Clin Pharmacokinet"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00549596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00549596\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00549596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T19:33:29Z","timestamp":1554406409000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00549596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1984,7]]}},"alternative-id":["BF00549596"],"URL":"https:\/\/doi.org\/10.1007\/bf00549596","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,7]]}}}